Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is administered as a subcutaneous injection once weekly, and proper injection site selection directly impacts medication absorption and patient comfort. PlexusDx compounded semaglutide is delivered by licensed 503A pharmacies and requires correct placement on the abdomen, thigh, or upper arm to achieve consistent therapeutic levels. Understanding injection anatomy helps patients achieve better outcomes while reducing injection-site reactions.
Approved Semaglutide Injection Sites on the Body
Semaglutide injections are administered into the subcutaneous tissue—the fatty layer beneath the skin but above muscle. Three body areas are approved for semaglutide injection: the abdomen, the outer thigh, and the back of the upper arm. The abdomen is the most commonly selected site because the subcutaneous tissue is consistently thick and accessible for self-injection. Many patients find the abdomen easiest to visualize and reach without assistance.
The outer thigh (lateral thigh) provides an alternative site suitable for patients with limited abdominal tissue or those who prefer variety. The back of the upper arm, also called the triceps area, works for patients who can reach it comfortably or with minimal assistance. All three sites have comparable absorption rates when injected correctly into subcutaneous tissue rather than muscle or dermis.
How to Rotate Injection Sites Safely
Site rotation prevents lipohypertrophy (thickened fatty tissue) and lipoatrophy (tissue loss), both of which can slow or accelerate medication absorption unpredictably. PlexusDx recommends selecting a new injection location with each weekly dose, staying at least one inch away from the previous injection site. Within the abdomen, patients can rotate between the left side, right side, and center area, creating a mental grid of six to eight distinct spots used in sequence.
Maintaining a simple rotation log—on paper or in a phone notes app—helps prevent accidentally re-injecting the same spot within two to four weeks. Inspecting injection sites monthly for signs of bumps, induration, or dimpling alerts patients to lipohypertrophy before it affects medication delivery. If a site looks or feels abnormal, skip it and return to it only after it returns to normal appearance.
Step-by-Step Injection Technique for Semaglutide
Begin by gathering your semaglutide pen or syringe, alcohol prep pad, and a sharps container. Wash your hands with soap and water, then clean the chosen injection site with the alcohol pad using a circular motion, starting from the center and moving outward. Allow the site to air-dry completely—injecting into wet alcohol can cause stinging and may affect absorption. Remove the needle cap just before injection.
Pinch the skin gently between your thumb and forefinger to create a small fold, then insert the needle at a 90-degree angle using one fluid motion. If using a pen device, press the injection button fully and hold for three seconds to ensure the full dose enters subcutaneous tissue. Release the skin fold, withdraw the needle, and apply gentle pressure with a clean gauze pad if needed—no rubbing. Dispose of the needle in a sharps container immediately.
Managing Injection Site Reactions and Comfort
Mild redness, swelling, or bruising at the injection site typically resolves within 24 to 48 hours and is not dangerous. Applying ice for 10 minutes before injection may reduce discomfort and bleeding; applying a warm compress afterward can ease soreness. Some patients report less injection-site pain when the medication is at room temperature rather than cold, so removing the pen from the refrigerator 15 minutes before injection may help. Rotating sites consistently remains the most effective way to prevent cumulative discomfort.
Persistent lumps, severe bruising, or signs of infection (warmth, pus, increasing redness) require medical attention. PlexusDx patients receiving compounded semaglutide should contact their prescriber if injection-site reactions worsen or do not resolve. Using a new needle for each injection, never reusing needles, and ensuring proper subcutaneous (not intramuscular or intradermal) placement all reduce adverse reactions. Proper technique and site rotation allow most patients to inject semaglutide comfortably for months.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into the same spot every week?
No. Injecting the same spot repeatedly causes lipohypertrophy or lipoatrophy, which distorts medication absorption. PlexusDx recommends rotating to a new site at least one inch away from the previous injection each week to maintain consistent therapeutic levels.
What happens if I inject semaglutide into muscle instead of fat?
Intramuscular injection can cause faster absorption and unpredictable blood levels. Semaglutide is formulated for subcutaneous delivery—the fatty layer under the skin. Proper technique with a 90-degree angle and skin pinching helps ensure the needle reaches subcutaneous tissue.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month from licensed 503A compounding pharmacies. Your dose may need to go up. Your price won't. No insurance is required, and the medication is HSA/FSA eligible.
Is it safe to have minor bruising or redness after a semaglutide injection?
Yes. Mild redness, swelling, or small bruises are normal and typically fade within 24 to 48 hours. Applying ice before injection or a warm compress afterward can reduce discomfort. However, persistent lumps, severe bruising, or signs of infection require medical attention.
Can genetic testing help me know if semaglutide will work better than tirzepatide?
Yes. PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence GLP-1 pathway responsiveness. Testing for $99 after your first treatment month helps personalize your therapy based on your genetic predisposition to semaglutide versus tirzepatide.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Journey: Do You Have to Eat Less on Ozempic?
Optimizing Your Ozempic Schedule: Is Taking It at Night the Optimal Choice?